DIBS Beauty’s Post

"The pessimist sees difficulty in every opportunity. The optimist sees opportunity in every difficulty." - Winston Churchill. In business and life, our perspective shapes our reality. Churchill's wisdom highlights the power of a positive outlook in navigating challenges and seizing opportunities. Optimism isn't about ignoring problems but approaching them with a solution-oriented mindset. It's the ability to see potential where others see roadblocks and to inspire teams to persevere through tough times. Cultivating this mindset can be the difference between giving up and breaking through for leaders and entrepreneurs. It fosters resilience, creativity, and adaptability – all crucial traits in today's dynamic business landscape. #OptimisticLeadership #ResilienceInBusiness #GrowthMindset #OpportunityMindset #EntrepreneurialSpirit My name is Gregory Lewandowski (lewandog), and I am on a continuous journey of self-improvement. 👉 Follow me here for more inspiring content and thought-provoking discussions. (https://lnkd.in/eeNzqPBs)

Now this is interesting news: https://lnkd.in/g6_8za3T... Swiss Pharmacan announced the full results of Phase II double-blind, placebo-controlled clinical trial for its anti-inflammatory treatment ArtemiC on persons diagnosed with COVID-19. ArtemiC met all the Phase II primary and secondary endpoints and demonstrated to improve the clinical recovery of COVID-19 patients. The results of the clinical trial on ArtemiC involving 50 patients show that the treatment statistically significantly improved the clinical recovery of COVID-19 patients in comparison with the Placebo Group. The results deliver a full safety and efficacy profile, demonstrating to improve and expedite the clinical recovery in moderate COVID-19 patients, with no drug-related adverse events. None of the patients supported by ArtemiC required additional oxygen, mechanical ventilation or intensive care, compared to 23.4% in the placebo group requiring further assistance. The trial was completed on 50 COVID-19 infected patients across 3 independent hospital sites in Israel and met all the FDA requirements for a COVID-19 study. These results now open potential market opportunities for ArtemiC to a wide range of diseases related to cytokine storm such as influenza, autoimmune diseases, inflammatory GI diseases and chemotherapy patients. Following the successful Phase II results, a Phase III clinical trial is planned for the first half of 2021. The Phase III trial is anticipated to be an international multicentre study to encompass a wide range of inflammatory indications for the use of ArtemiC as a treatment. Swiss Pharmacan has partnered with the Australian MGC Pharma for the clinical trial. US-based Relay Medical has acquired the exclusive North American rights for the manufacturing and sales of several products of Swiss Pharmacan.

Yesterday, I had the honor of listening in as a successor in training, my co-founder in our tech startup, Taynita Harilal my daughter bravely defend her dissertation topic towards obtaining her #PhD. Her presentation was outstanding, and I couldn't help but do a proud dance in the corner where I was hiding to sneak in and listen. All this took place while our President was being inaugurated. My pride overflowed as Taynita presented her research on succession planning and creating generational wealth for black females in family-owned businesses. Her pitch was impeccable. What I wasn't prepared for was the feedback from her panel of experts. All professors, all highly decorated doctors in their fields, critiqued and analyzed the potential study. There were moments I thought, if this were me, I would tell them to back off. But I watched this young lady, the same one who, just days before, advocated for workers to get paid regardless of personal grievances, and who holds us as leaders accountable for transparent and honest entrepreneurship. Taynita demonstrated grace, resilience, and an unwavering commitment to her values. She showed us how to walk away from anything that doesn't serve us and, with knowledge, that we can empower our hustle. As an academic, she has the blessing to command the presence of such highly esteemed individuals to form a panel just to listen to her. If, as leaders, we take the time to listen to people who show up for us, offer us safe advice, and implement their insights, entrepreneurship would be significantly enhanced. I am delighted to share that the panel approved her dissertation topic with minor changes. This journey to get her here shows me how knowledge and data matter, especially for black females on our continent and in our country, to unlock under-researched literature. In this case, a study focusing on Black Females in generational wealth in family-owned businesses will unlock opportunities to better position us, particularly in the context of the Fourth Industrial Revolution (4IR). Here are three key learnings from this experience: My daughter told me to be wary of men, even black men, who tell women like me, who have been in business for over 30 years, that we are problematic. This feeds into centuries of stereotyping. In this generation, we have to do better in how we close down and weaponize oppression against women. We need to use our agency. In our case, as a legacy brand with 20 years in business, we need to speak to be heard and use the data from our journey, expertise, and strengths. #Entrepreneurship is a journey, and not everyone is fortunate to have a knowledge-based legacy to back their build. Two things can be right at the same time, but let's build capacity by supporting our hustle with facts to build future models that validate credibility. This is a harder ask for women because we will always have to prove ourselves. #SuccessionPlanning https://lnkd.in/d8Wx2yM4

Mdm4/HdmX-Trap is our product of the month! Use this trap to pulldown Mdm4, a well-known inhibitor of p53. Like our other nano-traps, immunoprecipitation with the Mdm4-Trap results in clean, single-band pulldowns that can be completed in 60 minutes or less. Use this trap to isolate Mdm4 and some of its interacting co-factors, such as p21 and mTOR, to get a better idea of the upstream processes that lead to p53 inhibition in cancer. Use code FPOM20 while ordering and get 20% off all March long. Terms and conditions apply. View our Mdm4-Traps: https://ow.ly/XO1W50QJllH

Empower your legal journey with a unique story of resilience and entrepreneurship!  Join the conversation on crafting a compelling narrative and overcoming challenges. Watch the inspiring Q&A session here: https://lnkd.in/gQiShA4a #legalcareer #entrepreneurship #resilience

Embark on a transformative legal journey fueled by resilience and entrepreneurship! Dive into my unique story of crafting a compelling narrative and conquering challenges. Watch the inspiring Q&A session now to ignite your own path to success. Watch here: https://lnkd.in/gdgdSH32 #LegalJourney #Resilience #Entrepreneurship

📰 Year in Review: 2023 - A Year of Growth and Partnerships 🌟 As we wrap up the year, let's reflect on 2023—a year marked by growth and exciting new partnerships. Our latest blog delves into the milestones, collaborations, and strides we've made in advancing our mission. https://lnkd.in/eAzVZTjd #YearInReview #Growth #NewPartnerships

💥Clinical trials offer options & empower patients. Watch Mr. Bryant's inspiring story! https://lnkd.in/guvrvw9g In the video, you'll hear: ☑️Mr. Bryant's initial shock and fear upon receiving his diagnosis. ☑️How a clinical trial offered him vital treatment options, regardless of insurance status. ☑️Mr. Bryant's son-in-law's perspective on overcoming historical mistrust in the medical system due to the Tuskegee Experiment. Mr. Bryant's story is a testament to the power of clinical trials and the importance of seeking help. Watch the video and learn more about: 💡Clinical trials as an option for prostate cancer treatment. 💡How to navigate the healthcare system, especially for Black communities. 💡The importance of open communication with your doctor. Let's work together to break down barriers and ensure everyone can access quality healthcare. Visit https://lnkd.in/eBHqfcG3 to learn more. #BlackMenAndHealth #ProstateCancer #ClinicalTrials #HealthcareEquity #DiversityInResearch VIDEO CREDIT: FasterTogether.org

Review of Sudha Murty's Speech as a Presidential Nominee in Rajya Sabha It is with great respect and admiration that I reflect on the recent speech by our esteemed Sudha Murthy. Though her remarkable reputation precedes her, I cannot let this opportunity pass without expressing my deep gratitude for her inspiring words. In an impactful and concise speech, she demonstrated why she is an exceptional candidate for the Presidential nomination in Rajya Sabha. Over the course of 11 minutes (watch here : https://lnkd.in/gvX9f-cs ), she addressed key policy issues with remarkable clarity and precision, offering invaluable suggestions that highlighted her profound understanding and unwavering commitment to the nation's progress. Sudha Murthy's speech was a masterclass in effective communication. She navigated complex topics with unparalleled ease, providing insightful policy recommendations that were both practical and forward-thinking. Her ability to articulate her vision so precisely underscored her exceptional preparedness and steadfast dedication to public service. What stood out most was her unwavering emphasis on inclusive development and her strategic approach to policymaking. She seamlessly blended her vast experience with a compassionate perspective, advocating for solutions that address the diverse needs of our population. Her proposals were not only well-founded but also resonated with an urgent sense of feasibility. In summary, Sudha Murthy's speech was an exemplary demonstration of leadership and vision. Her on-the-dot delivery and the richness of her content reaffirmed her unparalleled suitability for the role of a Presidential nominee in Rajya Sabha. This speech is a must-watch for anyone interested in insightful and impactful policymaking. I extend my heartfelt thanks to Koshy Samuel for sharing this enlightening speech link. Your effort in bringing this valuable content to our attention is deeply appreciated. #SudhaMurthy #RajyaSabha #Leadership #PolicyMaking #PublicService #Inspiration #InclusiveDevelopment #KoshySamuel #SpeechReview #ImpactfulSpeeches #VisionaryLeadership

In a recent CEO group meeting, John Myrna, a 30-year member of Vistage, shared his courageous battle with cancer and sought guidance from his peers for planning his final months. The profound discussion underscored John's life, legacy, and the significant impact of the Vistage community on him, as well as the influence he had on his peers. Learn more about John's remarkable journey and the legacy he leaves behind. #StrategicPlanning #Legacy #Leadership